Introduction Flashcards
Article intended for the use in diagnosis, mitigation, cure, treatment, or prevent ion of disease in man/ animals
DRUG
Article (other than food) intended to affect the structure of any function of the body of human beings or animals
DRUG
Component which produces pharmacologic activity (Active Pharmaceutical Ingredient)
DRUG
Therapeutic moiety
DRUG
Inactive ingredient present in DF
EXCIPIENTS
Formulation containing a specific quantity of AI(s) in combination with one or more excipients
DOSAGE FORM
Final dosage form that contains the API, generally, but not necessarily, in association with other ingredients
DRUG PRODUCT/MEDICINE
Physical carriers used to deliver medications to specific areas
DRUG DELIVERY SYSTEMS
Means of administering drugs to the body in a safe, efficient, reproducible and convenient manner
DRUG DELIVERY SYSTEMS
Natural products should be free from:
Salmonella spp.
Oral Solutions and suspensions should be free from:
E. coli.
Topical products must be free from:
Pseudomonas aeruginosa
Urethral, vaginal and rectal should be free from:
total microbial count
high solubility, high permeability
class 1
low solubility, high permeability
class 2
high solubility, low permeability
class 3
low solubility, low permeability
class 4
The complete set of activities to produce a drug that comprise production and QC from dispensing of materials to the release for distribution of the finished product
Manufacturing
any organization or company involved in the manuf, import, packaging an d/or distribution of drugs or
medicines
Drug Establishment
Production of drug
Manufacturer
Registered owner, subcontracts the manufacturer, may
also engage in distribution and marketing
Trader
Imports/exports for own use or wholesale distribution
to other establishments
Distributor/
Importer/Exporter
Procures from a local establishment for local
distribution on wholesale basis
Distributor/
Wholesaler
Procures
meaning of PIC/S GMP 2009
Pharmaceutical Inspection Convention/ Co operation Scheme
System of QA aimed at ensuring that products are consistently manufactured to a quality appropriate for their intended use and is concerned with both manuf and QC processes and procedures
Good Manufacturing Practice (GMP)
Part of QA which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use
Good Manufacturing Practice (GMP)
holds the drug product and is or may be in direct contact with the drug product
CONTAINER
protects from extraneous solids and loss of article
Well closed
protects from contamination by extraneous liquid, solids, vapors, loss, efflorescence, deliquesence, or evaporation
Tight
impervious to air or any other gas
Hermetic
holds a quantity intended for single dose; cannot be resealed
Single dose
permits withdrawal of successive portions
Multiple dose
holds a quantity of a drug intended for admin as a single dose promptly after opening
Single unit
contains more than a single unit or dose
Multiple unit
not for under 5 years old
Child resistant
uses an indication or barrier to entry distinctive by design
Tamper evident
available in white flint (clear), amber, or colored
Glass
Type I glass
borosilicate
type II glass
treated SL (exempted form water attack
type III glass
soda lime
type IV (nonparenteral)
gen. SL
Polyethylene , Polyvinyl chloride, Polypropylene , Polystyrene
Plastic
Problems associated w/ plastic packaging material:
Permeability, Leaching, Sorption, Light transmission, Alteration upon storage
tin, aluminum, aluminum alloy
Metal
labels, cartons, layer boards
Paper and Board
sachets, seals, strips, blisters
Films, foils and laminations
closure for sterile products
Rubber
Not exceeding 8°C
Cold
-25 to 10°C
Freezer
2 to 8 °C
Refrigerator
8 to 15°C
Cool
2 to 8°C but allows excursions between 0 to 15°C
Controlled Room Temperature
20 to 25°C (prevailing in working area)
Room Temperature
30 to 40°C
Warm
Above 40°C
Excessive Heat
Does not exceed 40% of average RH at Controlled RT
Dry Place
Document that specifies all the tests to be conducted on a product and/or appropriate references containing details of procedure and expected result
Monograph
Document with the results of all tests conducted on material to show compliance or non
compliance with the standard specifications
Certificate of Analysis
This is concise and precise statement of the ingredients that comprise the product,
together with the percentage and/or weight of each.
Formula
This should enumerate the characteristics of all the materials that go into the product and the permissible range of purity of each ingredient.
Raw material specification
This is a step by step method on how to go about a job.
Standard Operating Procedure
This should cover all characteristics that affect the proper performance, purity, safety and
stability of the product.
Finished product specification
Finite number of objects selected from a batch
Sample
Capacity of drug to remain within specifications
STABILITY
Minimum Acceptable Potency Level:
90% Labeled Potency
excess medicaments in manufacturing unstable drugs
OVERAGE
ointment, suppositories, aerosols, creams, and foams
25% (should not exceed)
fluids
20% (should not exceed)
dry DFs
25% (should not exceed)